InflaRx N.V announced the appointment of Jan Medina, CFA, as Vice President and Head of Investor Relations of InflaRx. Medina brings over 25 years of extensive experience across the life sciences sector and capital markets, including in the areas of investor relations, communications and equity research. Medina joins InflaRx from Olink Proteomics where he was Vice President, Investor Relations & Capital Markets.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IFRX:
- InflaRx price target lowered to $8 from $9 at H.C. Wainwright
- InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
- InflaRx announces initiation of its commitment program for GOHIBIC
- InflaRx Announces Positive Topline Results from the Multiple Ascending Dose (MAD) Phase I Study with C5aR Inhibitor INF904
- InflaRx announces ‘positive’ topline results from MAD Phase I study of INF904
